Abingdon Health Plc

LSE ABDX.L

Abingdon Health Plc Receivables for the year ending June 30, 2024: USD 1.37 M

Abingdon Health Plc Receivables is USD 1.37 M for the year ending June 30, 2024, a 54.50% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.
  • Abingdon Health Plc Receivables for the year ending June 30, 2023 was USD 887.24 K, a -89.08% change year over year.
  • Abingdon Health Plc Receivables for the year ending June 30, 2022 was USD 8.13 M, a -35.58% change year over year.
  • Abingdon Health Plc Receivables for the year ending June 30, 2021 was USD 12.62 M, a 567.31% change year over year.
  • Abingdon Health Plc Receivables for the year ending June 30, 2020 was USD 1.89 M, a 0.00% change year over year.
Key data
Date Receivables Inventory Goodwill Total Assets
Market news
Loading...
SV Wall Street
LSE: ABDX.L

Abingdon Health Plc

CEO Mr. Chris Henry Francis Yates
IPO Date Dec. 15, 2020
Location United Kingdom
Headquarters York Biotech Campus
Employees 84
Sector Health Care
Industries
Description

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. The company also provides lateral flow development and manufacturing services. Additionally, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.

Similar companies

NCYT.L

Novacyt S.A.

USD 0.68

4.81%

GDR.L

genedrive plc

USD 0.03

-3.75%

AVCT.L

Avacta Group Plc

USD 0.60

0.85%

StockViz Staff

January 31, 2025

Any question? Send us an email